Big news!! ✨ So excited to see this incredible step towards improving birth control access for women and transforming the role of a pharmacist in the community! #TwitteRx

So excited to be able to attend my first in-person ASCO in Chicago! Excited for all the amazing science ahead ✨👩🏻‍🔬 #ASCO22

Diversity in clinical trials has continued to be a huge struggle. Happy to see nearly 20% AA enrollment in the DETERMINATION study! An excellent move towards more inclusive clinical trials within MM #ASCO2022

post MDW and still COVID free! *knocks on wood*

Pathogen or tumor: *mutate* Memory T cells: 👇 #MedTwitter #IDTwitter

⁦Myriam Chalabi⁩ said, “This is a waterfall plot,” and the whole audience in Hall 6 just laughed! Frankly, it’s not a waterfall plot… what you are looking at, in my opinion, is a lake. ⁦ESMO - Eur. Oncology⁩ #esmo22

Kicking off ASH 2022 with an obligatory pic of the logo! #ASH22

Who else is excited for ASCO?! I’ve got my comfiest shoes ready for a weekend full of exciting data! #ASCO23

Thank you to all who attended #IMS23 in person and virtually. Mark your calendars for next year's conference, to be held September 25-28 in Rio de Janeiro, Brazil. 🇧🇷We look forward to seeing you in 2024!

lol who did this

Congrats Drew Weissman ’81, MA’81, P’15, H'23. His work in messenger RNA led to the lifesaving vaccinations that altered the course of the COVID-19 pandemic. He won the The Nobel Prize in Physiology or Medicine, along with collaborator Katalin Karikó, H'23. brandeis.edu/stories/2023/o…

Excited to be reunited with friends and colleagues again in sunny SoCal for ASH! Don’t be a stranger if you see me running around, breaking in my new sneakers 👟 🩸#ASH23

Anybody know what cell this is supposed to be?! I’m calling it a malignant blueberry until further notice Krupa Patel #ASH23

BREAKING: U.S. FDA’s ODAC Recognizes MRD as an Accepted End Point for Accelerated Approval in Multiple Myeloma #mmsm #oncology onclive.com/view/fda-s-oda…

In conclusion👇the new FISH MM risk Myeloma Patients Europe International Myeloma Foundation Myeloma Patients Europe Rahul Banerjee, MD, FACP

Just out: Updated mSMART recommendations for treatment of relapsed refractory myeloma. #MedTwitter Mayo Myeloma 1/ CART is now included as an option for second or higher relapse. msmart.org/mm-treatment-g…

#mmsm #ASCO24 oral myeloma Nice discussion C. Ola Landgren, M.D. Nice summary tables of the presented studies along with other data using K instead of V 👇 Lots of thought provoking findings to get from those presentations

This World CML Day, join us in ensuring we build bridges, so that no patient is left behind. Find out more about what World CML Day is, this year’s theme, the focus of the iCMLf and how you can get involved - buff.ly/3yKdLgM #WCMLD24 #CML #iCMLf #CureCML

💡#TKI Tx is not just effective in #CML—it might impact psoriasis too!☝️ 📖 Read more in our lates article: [link.springer.com/10.1007/s00277…] #CML #TKI #Psoriasis #Hematology #Dermatology 📢 Springer Nature FN Brno Masarykova univerzita